Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways

BACKGROUND: Studies of insulin-like growth factor 1 (IGF-1) as a novel therapy for the treatment of cardiovascular diseases have proven promising. However, elevated IGF-1 levels have also been associated with poor patient outcomes in heart failure with reduced ejection fraction. IGF-1 therapy has ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kevin W., Wang, Ian H., Fu, Ping, Krum, Henry, Bach, Leon A., Wang, Bing H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349770/
https://www.ncbi.nlm.nih.gov/pubmed/34401470
http://dx.doi.org/10.1016/j.ijcha.2021.100852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349770/
https://www.ncbi.nlm.nih.gov/pubmed/34401470
http://dx.doi.org/10.1016/j.ijcha.2021.100852

Ejemplares similares